Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 443

1.

The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin.

Tahata Y, Hiramatsu N, Oze T, Morishita N, Harada N, Yamada R, Yakushijin T, Mita E, Hagiwara H, Yamada Y, Ito T, Hijioka T, Inada M, Katayama K, Tamura S, Yoshihara H, Inoue A, Imai Y, Irishio K, Kato M, Hikita H, Sakamori R, Miyagi T, Yoshida Y, Tatsumi T, Hamasaki T, Hayashi N, Takehara T.

J Gastroenterol. 2015 Jul 30. [Epub ahead of print]

PMID:
26223482
2.

Prognostic factors for survival in cervical cancer patients with bone metastasis.

Kanayama T, Mabuchi S, Shimura K, Hisamatsu T, Isohashi F, Hamasaki T, Kimura T.

Eur J Gynaecol Oncol. 2015;36(3):290-3.

PMID:
26189255
3.

Sample Size Considerations in Clinical Trials when Comparing Two Interventions using Multiple Co-Primary Binary Relative Risk Contrasts.

Ando Y, Hamasaki T, Evans SR, Asakura K, Sugimoto T, Sozu T, Ohno Y.

Stat Biopharm Res. 2015 Jun 24;7(2):81-94.

PMID:
26167243
4.

Clinical significance of fluctuations in thyroid hormones after surgery for Cushing's syndrome.

Tamada D, Kitamura T, Onodera T, Hamasaki T, Otsuki M, Shimomura I.

Endocr J. 2015 Jul 7. [Epub ahead of print]

5.

Reducing unnecessary measurements in clinical trials with multiple primary endpoints.

Sozu T, Sugimoto T, Hamasaki T.

J Biopharm Stat. 2015 Jun 22. [Epub ahead of print]

PMID:
26098617
6.

Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.

Nomura S, Suzuki Y, Takahashi R, Terasaki M, Kimata R, Terasaki Y, Hamasaki T, Kimura G, Shimizu A, Kondo Y.

BMC Urol. 2015 Jun 19;15:53. doi: 10.1186/s12894-015-0040-7.

7.

Design and Evaluation of New Unified Criteria for Disseminated Intravascular Coagulation Based on the Japanese Association for Acute Medicine Criteria.

Umemura Y, Yamakawa K, Kiguchi T, Yoshikawa Y, Ogura H, Shimazu T, Hamasaki T, Fujimi S.

Clin Appl Thromb Hemost. 2015 Jun 13. pii: 1076029615591169. [Epub ahead of print]

PMID:
26072118
8.
9.

Functional peptide nanocarriers for delivery of novel anti-RelA RNA interference agents as a topical treatment of atopic dermatitis.

Kanazawa T, Hamasaki T, Endo T, Tamano K, Sogabe K, Seta Y, Ohgi T, Okada H.

Int J Pharm. 2015 Jul 15;489(1-2):261-7. doi: 10.1016/j.ijpharm.2015.05.003. Epub 2015 May 5.

PMID:
25956048
10.

Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis.

Yoshimura J, Yamakawa K, Ogura H, Umemura Y, Takahashi H, Morikawa M, Inoue Y, Fujimi S, Tanaka H, Hamasaki T, Shimazu T.

Crit Care. 2015 Mar 3;19:78. doi: 10.1186/s13054-015-0810-3.

11.

Group-Sequential Strategies in Clinical Trials with Multiple Co-Primary Outcomes.

Hamasaki T, Asakura K, Evans SR, Sugimoto T, Sozu T.

Stat Biopharm Res. 2015;7(1):36-54.

PMID:
25844122
12.

Ossification of the posterior longitudinal ligament of the cervical spine in 3161 patients: a CT-based study.

Fujimori T, Le H, Hu SS, Chin C, Pekmezci M, Schairer W, Tay BK, Hamasaki T, Yoshikawa H, Iwasaki M.

Spine (Phila Pa 1976). 2015 Apr 1;40(7):E394-403. doi: 10.1097/BRS.0000000000000791.

PMID:
25811134
13.

The Advantage of a Ureteroscopic Navigation System with Magnetic Tracking in Comparison with Simulated Fluoroscopy in a Phantom Study.

Yoshida K, Yokomizo A, Matsuda T, Hamasaki T, Kondo Y, Yamaguchi K, Kanayama HO, Wakumoto Y, Horie S, Naito S.

J Endourol. 2015 May 7. [Epub ahead of print]

PMID:
25793540
14.

Characterization of patients with angioscopically-detected in-stent mural thrombi – genetics of clopidogrel responsiveness and generations of drug-eluting stents.

Ichikawa M, Takei Y, Hamasaki T, Kijima Y.

Circ J. 2015;79(1):85-90. doi: 10.1253/circj.CJ-14-0639. Epub 2014 Oct 30.

15.

Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex.

Wataya-Kaneda M, Tanaka M, Yang L, Yang F, Tsuruta D, Nakamura A, Matsumoto S, Hamasaki T, Tanemura A, Katayama I.

JAMA Dermatol. 2015 Jul 1;151(7):722-30. doi: 10.1001/jamadermatol.2014.4298.

PMID:
25692384
16.

Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study.

Takahashi R, Mabuchi S, Kawano M, Sasano T, Matsumoto Y, Kuroda H, Hisamatsu T, Kozasa K, Sawada K, Hamasaki T, Kimura T.

Gynecol Oncol. 2015 Apr;137(1):112-8. doi: 10.1016/j.ygyno.2015.02.006. Epub 2015 Feb 11.

PMID:
25680864
17.

Olfactory auras caused by a very focal isolated epileptic network in the amygdala.

Hamasaki T, Otsubo H, Uchikawa H, Yamada K, Kuratsu J.

Epilepsy Behav Case Rep. 2014 Aug 24;2:142-4. doi: 10.1016/j.ebcr.2014.07.002. eCollection 2014.

18.

Successful management of pregnancy with very-long-chain acyl-coenzyme A dehydrogenase deficiency.

Yamamoto H, Tachibana D, Tajima G, Shigematsu Y, Hamasaki T, Tanaka A, Koyama M.

J Obstet Gynaecol Res. 2015 Jul;41(7):1126-8. doi: 10.1111/jog.12672. Epub 2015 Feb 6.

PMID:
25655073
19.

Postprocedural Skin Perfusion Pressure Correlates With Clinical Outcomes 1 Year After Endovascular Therapy for Patients With Critical Limb Ischemia.

Okamoto S, Iida O, Nakamura M, Yamauchi Y, Fukunaga M, Yokoi Y, Soga Y, Zen K, Hirano K, Suematsu N, Suzuki K, Shintani Y, Miyashita Y, Urasawa K, Kitano I, Yamaoka T, Ohura N, Hamasaki T, Uematsu M, Nanto S; on behalf of the OLIVE Investigators.

Angiology. 2015 Feb 4. pii: 0003319715569907. [Epub ahead of print]

PMID:
25653244
20.

B-type natriuretic peptide-guided risk assessment for postoperative complications in lung cancer surgery.

Nojiri T, Inoue M, Shintani Y, Takeuchi Y, Maeda H, Hamasaki T, Okumura M.

World J Surg. 2015 May;39(5):1092-8. doi: 10.1007/s00268-015-2943-6.

PMID:
25585524
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk